IMVT
$26.73-2.84%
Immunovant Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.02%Russell 3000 0.005%US Stock Market 0.004%
Immunovant Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Immunovant Inc. total returns by year (2020–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $25.42 | $26.73 | 0.0% | +5.2% | |
| 2025 | $24.77 | $25.42 | 0.0% | +2.6% | |
| 2024 | $42.13 | $24.77 | 0.0% | -41.2% | |
| 2023 | $17.75 | $42.13 | 0.0% | +137.4% | |
| 2022 | $8.52 | $17.75 | 0.0% | +108.3% | |
| 2021 | $46.19 | $8.52 | 0.0% | -81.6% | |
| 2020 | $15.87 | $46.19 | 0.0% | +191.1% |
- Annualized
- +14.7%
- 2020–2026
- Average year
- +52.8%
- 6 full years
- Best year
- +191.1%
- 2020
- Worst year
- -81.6%
- 2021
- Positive years
- 4/6
- 67% up
Annualized (CAGR)
+14.7%
2020–2026
Average year
+52.8%
6 full years
Best year
+191.1%
2020
Worst year
-81.6%
2021
Positive years
4/6
67% up
Total return by period#
Annual
-100%0%100%
2020+191%'20
2021-82%'21
2022+108%'22
2023+137%'23
2024-41%'24
2025+2.6%'25
2026+5.2%'26
Methodology#
Total returns, dividends reinvested, measured on IMVT. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Immunovant Inc.'s average annual return?
- Since 2020, Immunovant Inc. (IMVT) has returned about 14.7% a year (the compound annual growth rate) and an average calendar-year return of 52.8%.
- What were Immunovant Inc.'s best and worst years?
- Over 2020–2026, the best year was 2020 (+191.1%) and the worst was 2021 (-81.6%).
- How often is Immunovant Inc. up in a year?
- 4 of the 6 full years since 2020 were positive — about 67% of the time.
More on Immunovant Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100